Search results
FDA advisory panel recommends new Alzheimer's drug after scrutiny
United Press International via Yahoo News· 4 days agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
Clear need to improve NHS screening for new Alzheimer’s drugs – study
Press Association News via AOL· 3 days agoThere is a “clear and urgent” need to improve NHS screening to work out who may benefit from new ...
Advisory Panel of Experts Endorses FDA Approval of New Alzheimer’s Drug
The New York Times via Yahoo News· 4 days agoA committee of independent advisers to the Food and Drug Administration voted unanimously Monday...
Alzheimer's Disease Drug Leqembi May Get New Dosing Schedule
Healthline· 2 days agoAn Alzheimer’s disease drug may soon have a new dosing schedule. The medication, Leqembi, is...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 3 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
New Alzheimer’s treatment could bring hope to local families impacted by the disease
WPXI· 2 days agoAbout 280,000 people in Pennsylvania are living with a heart-wrenching disease called Alzheimer’s....
FDA panel endorses approval of Alzheimer’s drug shown to slow progression of disease
WSB Radio· 3 days agoIf approved by the FDA, Eli Lilly’s Alzheimer’s drug donanemab, would become the second Alzheimer’s
Study reveals combined use of Donepezil/Memantine increases probability of five-year survival in ...
Medical Xpress· 2 days agoNow, a new study led by Chapman University researchers has explored the efficacy of using two...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 5 days agoA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
Courthouse News Service· 4 days agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...